ArticleClinical, cosmetic and investigational dermatology2024
Long-Standing Remission After Tildrakizumab Treatment in a Case of Refractory Type I Pityriasis Rubra Pilaris in a Breast Cancer Patient.
Vito Di Lernia et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.